As of 9:38am ET
| +0.54 / +0.77%|
STERIS Corp. is engaged in the provision of infection prevention and other procedural products and services, focused on healthcare, pharmaceutical, and research industries. It operates through three segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment manufactures and sells infrastructure capital equipment and provides consumable, information support, and service solutions. The Life Sciences segment serves pharmaceutical manufacturers and research organizations by providing decontamination and sterilization technologies, products and services. The STERIS Isomedix Services segment provides ethylene oxide and/or irradiation services on a contract basis through a network of facilities in North America. The company was formerly known as Innovative Medical Technologies and changed its name to STERIS Corp. in 1987. STERIS was founded by Raymond C. Kralovic and Edward T. Schneider in August 9, 1985 and is headquartered in Mentor, OH.
|Walter M. Rosebrough||President, Chief Executive Officer & Director|
|Michael J. Tokich||Chief Financial Officer, Treasurer & Senior VP|
|Peter A. Burke||Chief Technology Officer & Senior Vice President|
|Robert E. Moss||Group President-Isomedix Services & Senior VP|
|Kathleen Lynn Bardwell||Chief Compliance Officer & Senior Vice President|